TP53 and hepatocellular carcinoma: This finding aligns with established literature [13] showing that P53-mutated HCC exhibits characteristic reductions in the relative enhancement ratio (RER) during HBP imaging—a phenomenon mechanistically linked to downregulated expression of the OATP1B3 transporter on tumor cell membranes [28].